Back
Akero Therapeutics Vs. IperionX Industry Stock Comparison
Sell
34
AKRO
Akero Therapeutics
Last Price:
$28.21
Seasonality Move:
-11.78%
Buy
80
IPX
IperionX
Last Price:
$33.59
Seasonality Move:
35.72%
Sell
34
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $28.24. The Score for AKRO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $28.24Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight selling pressure.
IPX Stock Price Chart
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.72 | Sell |
Relative Strength Index (14 RSI): | 42.96 | Sell |
Chaikin Money Flow: | -88048 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.28 - 31.02) | Sell |
Bollinger Bands (100): | (26.59 - 31.33) | Sell |
IPX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.07 | Buy |
Relative Strength Index (14 RSI): | 59.58 | Buy |
Chaikin Money Flow: | -38736 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.35 - 32.83) | Buy |
Bollinger Bands (100): | (17.89 - 28.55) | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.27 | Sell |
20-day SMA: | 29.17 | Sell |
50-day SMA: | 30.5 | Sell |
200-day SMA: | 25.9 | Buy |
8-day EMA: | 28.35 | Sell |
20-day EMA: | 29.07 | Sell |
50-day EMA: | 29.58 | Sell |
200-day EMA: | 27.86 | Buy |
IPX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.29 | Buy |
20-day SMA: | 30.39 | Buy |
50-day SMA: | 27.14 | Buy |
200-day SMA: | 18.86 | Buy |
8-day EMA: | 33.26 | Buy |
20-day EMA: | 31.04 | Buy |
50-day EMA: | 27.87 | Buy |
200-day EMA: | 20.33 | Buy |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.90 per share, and an increase next year of $0.20 per share.
IperionX Earnings Growth & IPX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.13 per share.
Akero Therapeutics Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
IperionX Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |